Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Warts Therapeutics Market Evolve in Terms of Growth and Size by 2029?

The market size of warts therapeutics has experienced consistent growth over the past few years. Its projected growth will rise from $1.96 billion in 2024 to $2.01 billion in 2025, with a compound annual growth rate (CAGR) of 2.6%. Factors that contributed to this growth during the historic period include the utilization of salicylic acid, advancements in cryotherapy, progression in topical treatments, surgical interventions, and the advent of immunotherapy.

In the coming years, the warts therapeutics market size is anticipated to witness consistent growth. The market is predicted to expand to “$2.36 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 4.1%. This projected growth during the forecast period can be accredited to precision medicine targeting HPV, innovations in laser therapy, combination therapy methods, digital health advancements, and initiatives promoting accessibility to healthcare. Noteworthy trends over the forecast period will include an emphasis on targeted antiviral therapies, gene editing studies, the development of biodegradable delivery systems, and a focus on psychodermatology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11959&type=smp

What factors are expected to fuel Warts Therapeutics market growth in the coming years?

The growth of the wart therapeutics market is set to be propelled by the surging emphasis on warts vaccination. The concept of vaccination involves the introduction of a vaccine into the body to stimulate the development of antibodies against infections and associated diseases. Warts are the result of the human papillomavirus (HPV). Giving a prophylactic or therapeutic vaccine against HPV halts wart formation. As a result, growing attention towards wart vaccination ramps up the wart therapeutics market sales. For example, the World Health Organization, an international public health agency based in Switzerland, reported in July 2023 that in 2022, there was a reduction in the count of children who didn’t receive any vaccinations, often known as zero-dose children. This decreased from 18.1 million in 2021 to 14.3 million. In addition, global initiation dose coverage of the HPV vaccine for girls escalated from 16% in 2021 to 21% in 2022. Consequently, the soaring focus on warts vaccination is fueling the development of the wart therapeutics market.

The warts therapeutics market covered in this report is segmented –

1) By Type: Common Warts, Genital Warts, Flat Warts, Other Types

2) By Treatment: Physical Destruction, Immunomodulation, Chemical Destruction

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Common Warts: Typically Appear On Hands, Fingers, And Elbows, Caused By Human Papillomavirus (HPV) Types 2 And 4

2) By Genital Warts: Occur In The Genital And Anal Areas, Primarily Caused By HPV Types 6 And 11

3) By Flat Warts: Smaller And Smoother Than Common Warts, Commonly Found On The Face, Neck, And Arms

4) By Other Types: Includes Plantar Warts (On Feet) And Filiform Warts (Around The Mouth And Nose), Various HPV Types Can Cause These Warts

What Notable Trends Are Shaping The Direction Of The Warts Therapeutics Market?

The key trend that is gaining traction in the wart therapeutics market is product innovation. Firms working in the wart therapeutics market are concocting innovative therapies to maintain their market standing. For example, Verrica Pharmaceuticals Inc., a dermatology therapeutics business based in the United States, disclosed in February 2023 that its re-filed New Drug Application (NDA) for VP-102, a treatment for molluscum contagiosum (a wart variety), was approved by the FDA (The United States Food and Drug Administration) and allocated a Prescription Drug User Fee Act (PDUFA) number. VP-102 is a unique drug-device combo product that provides cantharidin (0.7% w/v) in a GMP-governed mixture using a single-use applicator for precise topical dosing and targeted administration.

What Are The Most Active Companies In The Warts Therapeutics Market Today?

Major companies operating in the warts therapeutics market include GlaxoSmithKline plc, Merck & Co. Inc., Verrica Pharmaceuticals Inc., Bausch Health Companies Inc., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Prestige Consumer Healthcare Inc., Maruho Co. Ltd, Taro Pharmaceutical Industries Ltd, Aclaris Therapeutics Inc., Novan Inc, Scholl’s Wellness Co, AIM ImmunoTech Inc., Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Nielsen BioSciences Inc., RXi Pharmaceuticals, Phio Pharmaceuticals Corp., MedCara Pharmaceuticals, KinoPharma Inc., pHion Therapeutics, Compound W, Duofilm, Curad Mediplast, Emblation Ltd.

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Which Regional Markets Are Attracting The Most Investment In Warts Therapeutics?

North America was the largest region in the warts therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the warts therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11959&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model